A $3 billion China investment targets localized oral solid-dose manufacturing and supply-chain redundancy to support ...
SteinCares and Shilpa Biologicals have entered a licensing agreement to commercialize biosimilars in Latin America. Under the deal, SteinCares will manage regional registration and distribution, while ...
Orphan drugs are forecast to surpass $400 billion in 2032 sales, driven by accelerating rare disease innovation despite regulatory volatility, pricing pressures, and capital competition from ...
Kroger’s retail rollout shifts Zepbound KwikPen distribution from direct-to-consumer to community pharmacy channels, potentially reducing friction in initiation and refills for GLP-1 obesity therapy.
Data provided by BackOps indicates significant performance gains for early adopters across various industries, including retail, grocery, and manufacturing. The platform reportedly accelerates ...
In today’s Pharma Pulse, the FDA launched a unified monitoring system to enable real-time adverse event reporting, and direct-to-employer drug purchasing models are emerging as companies look to ...
In a recent interview, Jay Bregman, founder and CEO of Andel, discussed his company's newly launched direct-to-employer medication platform, which is designed to reduce prescription drug costs by ...
In today’s Pharma Pulse, Antengene and UCB ink a $1.18 billion global deal for ATG-201 to target autoimmune diseases, while ...
SpotSee and Controlant announced a collaboration to enhance pharmaceutical supply chain visibility using integrated ...
Agreement enables Hims & Hers users to access branded Ozempic 0.5–2 mg and Wegovy injectable 0.25–2.4 mg plus oral strengths 1.5–25 mg. Hims & Hers will cease marketing compounded GLP-1 products and ...
Thermal testing can make or break cold chain performance. Join this webinar to learn proven best practices that help eliminate blind spots, validate designs, and protect temperature-sensitive ...
The FDA launched AEMS, a unified platform that replaces fragmented legacy databases to enable real-time adverse event reporting.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results